Eli Contorno
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Undergraduate
Also affiliated: Arkansas Children's Hospital (2024–2025); Children's Mercy Hospital (2024); Augusta University (2024); Arkansas Children's Research Institute (2025)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Eli Contorno's research focuses on pediatric cardiovascular conditions and organ transplantation. His work includes investigating options for pediatric heart valve replacement and examining the suitability of infant heart transplant recipients to serve as domino partial heart transplant donors. Contorno also studies the viability of partial heart transplant grafts during prolonged cold preservation, which suggests potential for extended donor cold chain logistics. His publications address various cardiac conditions, including Tetralogy of Fallot and Pulmonary Atresia with Ventricular Septal Defect, as well as tracheal allotransplantation for growing airway implants in infants and children. Contorno collaborates with researchers at the University of Arkansas for Medical Sciences, including Herra Javed, Brian Reemtsen, John Lowery, and Taufiek Konrad Rajab.
Metrics
- h-index: 4
- Publications: 14
- Citations: 26
Positions
-
Undergraduate publications 2025–2026University of Arkansas at Fayetteville Institution web page
Selected Publications
-
Cellular and Biomechanical Changes in Heart Valve Allografts following Vitrification (2026)Journal of the Arkansas Academy of Science OpenAlex
-
Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo (2025)
-
Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023 (2025)
Collaboration Network
Top Collaborators
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Treatment Strategies and Outcomes in Pulmonary Atresia With Ventricular Septal Defect Without Major Aortopulmonary Collateral Arteries in North America 2003-2023
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
- Abstract 4371518: Vitrified Partial Heart Transplants Grow at the Same Rate as Fresh Partial Heart Transplants and Retain Viable Donor Cells In-Vivo
Similar Researchers
Based on overlapping research topics